Single-dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK-1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects.

Single-dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK-1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjects. — المؤلف: Crutchlow, Michael F — Diabetes, obesity & metabolism 20181227

المؤلف
Crutchlow, Michael F
النشر
Diabetes, obesity & metabolism 20181227
الوصف
400-408 p.
الموضوعات
Adult؛ Biosimilar Pharmaceuticals؛ Biotransformation؛ Blood Glucose؛ Cross-Over Studies؛ Diabetes Mellitus, Type 1؛ Double-Blind Method؛ European Union